Associated Papers
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading.
Sudhakar N et al.
Molecular Cancer Therapeutics, 2024
38904222 (PubMed )
Supplement: mct-23-0870_supplementary_table_s1_supps1.pdf
Select a paper to view details